Placental Site Trophoblastic Tumor: A 17-Year Experience at the New England Trophoblastic Disease Center
- 30 September 2001
- journal article
- review article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 82 (3), 415-419
- https://doi.org/10.1006/gyno.2001.6265
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine Chemotherapy and Patients Presenting With Metastatic Placental Site Trophoblastic TumorsJournal of Clinical Oncology, 2000
- MR appearance of placental site trophoblastic tumor: a report of three cases.American Journal of Roentgenology, 1998
- Metastatic Placental Site Trophoblastic Tumor: Long-Term Remission in a Patient Treated with EMA/CO ChemotherapyGynecologic Oncology, 1998
- MR appearance of placental site gestational trophoblastic neoplasmClinical Imaging, 1996
- Clinical characteristics of placental site trophoblastic tumor (PSTT)Gynecologic Oncology, 1988
- Trophoblastic pseudotumor—Evidence of malignant disease potentialGynecologic Oncology, 1981
- Trophoblastic pseudotumorThe American Journal of Surgical Pathology, 1981
- Trophoblastic pseudotumor of the uterus.An exaggerated form of “syncytial endometritis” simulating a malignant tumorCancer, 1976